Elevance Health, Inc. $ELV Stock Holdings Lifted by Cambiar Investors LLC

Cambiar Investors LLC boosted its stake in Elevance Health, Inc. (NYSE:ELV) by 12.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 167,780 shares of the company’s stock after buying an additional 18,730 shares during the quarter. Elevance Health makes up 2.5% of Cambiar Investors LLC’s investment portfolio, making the stock its 10th largest holding. Cambiar Investors LLC’s holdings in Elevance Health were worth $54,213,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of the company. Vermillion & White Wealth Management Group LLC grew its stake in shares of Elevance Health by 94.9% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 76 shares of the company’s stock worth $30,000 after acquiring an additional 37 shares in the last quarter. BOK Financial Private Wealth Inc. bought a new stake in Elevance Health in the 2nd quarter worth about $32,000. Motco increased its stake in Elevance Health by 334.8% in the 3rd quarter. Motco now owns 100 shares of the company’s stock valued at $32,000 after buying an additional 77 shares during the last quarter. True Wealth Design LLC increased its stake in Elevance Health by 431.8% in the 3rd quarter. True Wealth Design LLC now owns 117 shares of the company’s stock valued at $38,000 after buying an additional 95 shares during the last quarter. Finally, Glass Jacobson Investment Advisors llc lifted its position in shares of Elevance Health by 400.0% during the 2nd quarter. Glass Jacobson Investment Advisors llc now owns 100 shares of the company’s stock worth $39,000 after buying an additional 80 shares in the last quarter. 89.24% of the stock is owned by hedge funds and other institutional investors.

Elevance Health Price Performance

Shares of NYSE:ELV opened at $322.55 on Wednesday. The firm has a market capitalization of $71.68 billion, a PE ratio of 13.19, a P/E/G ratio of 1.94 and a beta of 0.51. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.71. The company has a 50-day moving average price of $350.06 and a two-hundred day moving average price of $328.78. Elevance Health, Inc. has a twelve month low of $273.71 and a twelve month high of $458.75.

Analysts Set New Price Targets

ELV has been the subject of several recent analyst reports. TD Cowen reaffirmed a “buy” rating on shares of Elevance Health in a report on Wednesday, November 26th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $320.00 price objective (down previously from $332.00) on shares of Elevance Health in a research note on Friday, December 19th. Morgan Stanley lowered their target price on Elevance Health from $359.00 to $352.00 and set an “equal weight” rating on the stock in a research note on Wednesday, December 17th. Robert W. Baird increased their price target on shares of Elevance Health from $297.00 to $340.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Finally, Wells Fargo & Company raised their price objective on shares of Elevance Health from $403.00 to $424.00 and gave the stock an “overweight” rating in a report on Wednesday, January 7th. Twelve investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, Elevance Health has an average rating of “Moderate Buy” and an average target price of $399.63.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.